Snowball logo
logo
4164

CHC Healthcare Group

4164 โ€ข TW
NT$26.50-NT$0.65ย  (2.39%)
Estimate
P/E
22.3
EPS
1.19
Beta
0.179
Growth
Revenue, YoY
8.85%
Net income, YoY
53.8%
FCF, YoY
17.07%
Forecast
P/E (FWD)
8.1
EPS (FWD)
3.28
About the company
Ticker
4164
ISIN
TW0004164009
Country
Taiwan
Sector (GICS)
Healthcare
CHC Healthcare Group, together with its subsidiaries, trades in medical equipment, pharmaceutical products, and health food in Taiwan, China, and internationally. The company is also involved in the leasing, installing, servicing, and repairing of medical instruments for use in various specialties, such as radiation oncology, medical imaging, neurology, surgery, ophthalmology, robot rehabilitation, dentistry, and smart health care. In addition, it engages in the irradiation business; sale of daily necessities, beauty products, and health supplements; elderly residence, long-term care, and senior services; leasing of veterinary medical instruments; department setup, business management consultation, and educational training and staff development for healthcare personnel; technical support and maintenance; radiation sterilization business; and online and physical store pharmacy chain activities. The company was formerly known as Cheng Yeh Holdings Co., Ltd. and changed its name to CHC Healthcare Group in 2012. CHC Healthcare Group was incorporated in 2009 and is headquartered in Taipei, Taiwan.

Frequently asked questions

What sector does CHC Healthcare Group (4164) operate in?

CHC Healthcare Group belongs to the Healthcare sector and operates in the Medical Distribution industry.

What is CHC Healthcare Group (4164) current stock price?

As of the latest data, CHC Healthcare Group stock price is NT$26.50, with a previous close of NT$27.15. CHC Healthcare Group lost -NT$0.65 in the last trading session, representing a -2.39% loss.

What is CHC Healthcare Group (4164) current market capitalization?

CHC Healthcare Group market cap is approximately 5.14 billion.

What is CHC Healthcare Group (4164) Earnings Per Share (EPS)?

The trailing EPS is NT$1.19, and the forward EPS is NT$3.28.

What is CHC Healthcare Group (4164) Price-to-Earnings (P/E) ratio?

CHC Healthcare Group current P/E ratio is 22.27, with a forward P/E of 8.08.

What is CHC Healthcare Group (4164) EBITDA?

CHC Healthcare Group EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 264.80 million.

Does CHC Healthcare Group (4164) pay dividends?

No. CHC Healthcare Group does not pay a dividend.

What is CHC Healthcare Group (4164) beta (volatility) score?

CHC Healthcare Group has a beta of 0.179, indicating lower volatility than the overall market.